Long-term disability and progression in spinal onset multiple sclerosis

被引:0
|
作者
Bedile Irem Tiftikcioglu
Irem Ilgezdi
Yasar Zorlu
Ufuk Sener
Figen Tokucoglu
机构
[1] TCSB Izmir Tepecik Education and Research Hospital,Department of Neurology
来源
Acta Neurologica Belgica | 2018年 / 118卷
关键词
Multiple sclerosis; Initial relapse; Spinal cord; Progression; Recovery; Outcome;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study is to investigate the long-term effects of the initial spinal cord (SC) involvement in MS patients. In this retrospective, single-center study, 824 patients with definite MS were screened. A total of 348 patients were excluded for ambiguous documentation of the initial relapse, pediatric onset, diagnosis of primary progressive disease, irregular assessments or visits causing doubt on the onset of progression time, and clinical follow-up duration less than 12 months. Eventually, 476 MS patients were included. Data regarding the demographics, initial symptoms, the degree of recovery from the initial relapse, neuroimaging, cerebrospinal fluid analysis, long-term disability, and progression were collected from the medical registry. The mean duration of follow-up was 7.49 ± 5.30 years. The percentage of patients entering the progressive disease course was 23.3 in the whole group. A total of 157 patients (33.0%) had SC involvement during the first clinical relapse. These patients were significantly older at disease onset (31.69 ± 10.18 vs. 29.55 ± 9.49; p = 0.028), had higher rates of progression (32.5 vs. 18.8%; p = 0.001), and had higher disability scores in long-term follow-up (3.41 ± 2.19 vs. 2.62 ± 1.81; p < 0.001). Mean age at the transition of progressive phase was 41.4 ± 11.2 years. The degree of recovery from the initial relapse significantly affected the long-term disability. The poor recovery from the initial relapse was associated with older onset age and higher EDSS scores. Being older than 40 years during MS onset and poor recovery from the initial relapse exerted an increased risk for progression. The initial SC involvement was related to a more severe relapse with less chance of complete recovery and higher risk for progression. Confirmation of risk factors in different MS cohorts would increase our understanding of the complex disease mechanisms.
引用
收藏
页码:217 / 225
页数:8
相关论文
共 50 条
  • [21] Prognostic factors associated with long-term disability and secondary progression in patients with Multiple Sclerosis
    Ferreira Vasconcelos, Claudia Cristina
    Kallenbach Aurencao, Juliana Calvet
    Santos Thuler, Luiz Claudio
    Camargo, Solange
    Alvarenga, Marcos Papais
    Papais Alvarenga, Regina Maria
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 8 : 27 - 34
  • [22] Long-term treatment effect over disability progression in patients with relapsing multiple sclerosis
    Casanova Estruch, B.
    Perez-Miralles, F. C.
    Gascon, F.
    Alcala, C.
    Navarre, A.
    Bernat, A.
    Bosca, I.
    Escutia, M.
    Gil-Perotin, S. G.
    Coret, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 117 - 118
  • [23] Predicting long-term sustained disability progression in multiple sclerosis: application in the CLARITY trial
    Sharmin, Sifat
    Bovis, Francesca
    Sormani, Maria Pia
    Butzkueven, Helmut
    Kalincik, Tomas
    NEUROLOGY, 2021, 96 (15)
  • [24] Disability progression ratio: Long-term 103 month rehabilitation outcome in multiple sclerosis
    Cendrowski, C. S. P.
    Kwolek, A.
    Wieliczko, E.
    MULTIPLE SCLEROSIS, 2007, 13 : S109 - S110
  • [25] Multiple sclerosis relapses contribute to long-term disability
    Scott, Thomas F.
    Diehl, Daniel
    Elmalik, Wisam
    Gettings, Edward J.
    Hackett, Chris
    Schramke, Carol J.
    ACTA NEUROLOGICA SCANDINAVICA, 2019, 140 (05): : 336 - 341
  • [26] Interferon Beta and Long-term Disability in Multiple Sclerosis
    Shirani, Afsaneh
    Zhao, Yinshan
    Karim, Mohammad Ehsanul
    Evans, Charity
    Kingwell, Elaine
    van der Kop, Mia L.
    Oger, Joel
    Gustafson, Paul
    Petkau, John
    Tremlett, Helen
    JAMA NEUROLOGY, 2013, 70 (05) : 651 - 652
  • [27] Prognostic significance of free light chains for long-term and short term disability progression in multiple sclerosis
    Nazarov, V.
    Makshakov, G.
    Lapin, S.
    Evdoshenko, E.
    Surkova, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 789 - 789
  • [28] Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
    Rocca, Maria A.
    Sormani, Maria Pia
    Rovaris, Marco
    Caputo, Domenico
    Ghezzi, Angelo
    Montanari, Enrico
    Bertolotto, Antonio
    Laroni, Alice
    Bergamaschi, Roberto
    Martinelli, Vittorio
    Comi, Giancarlo
    Filippi, Massimo
    BRAIN, 2017, 140 : 2814 - 2819
  • [29] Long-Term Evolution of Multiple Sclerosis Disability in the Treatment Era
    Cree, Bruce A. C.
    Gourraud, Pierre-Antoine
    Oksenberg, Jorge R.
    Bevan, Carolyn
    Crabtree-Hartman, Elizabeth
    Gelfand, Jeffrey M.
    Goodin, Douglas S.
    Graves, Jennifer
    Green, Ari J.
    Mowry, Ellen
    Okuda, Darin T.
    Pelletier, Daniel
    von Buedingen, H-Christian
    Zamvil, Scott S.
    Agrawal, Alisha
    Caillier, Stacy
    Ciocca, Caroline
    Gomez, Refujia
    Kanner, Rachel
    Lincoln, Robin
    Lizee, Antoine
    Qualley, Pamela
    Santaniello, Adam
    Suleiman, Leena
    Bucci, Monica
    Panara, Valentina
    Papinutto, Nico
    Stern, William A.
    Zhu, Alyssa H.
    Cutter, Gary R.
    Baranzini, Sergio
    Henry, Roland G.
    Hauser, Stephen L.
    ANNALS OF NEUROLOGY, 2016, 80 (04) : 499 - 510
  • [30] Interferon Beta and Long-term Disability in Multiple Sclerosis reply
    Greenberg, Benjamin M.
    Frohman, Elliot
    JAMA NEUROLOGY, 2013, 70 (05) : 652 - 653